AI in Healthcare

Can AI truly redefine what's possible in medicine? Today, August 6, 2026, news from the Mayo Clinic, highlighted by Technology Networks, showcases an AI-designed drug targeting a previously "undruggable" cancer protein. This experimental drug, developed with AI's help in screening nearly 40,000 compounds, demonstrated the ability to slow tumor growth and improve survival in lab studies for treatment-resistant cancers like pancreatic cancer. This breakthrough underscores AI's profound potential to expand therapeutic options and accelerate discovery timelines for complex diseases. What are your thoughts on AI's role in tackling currently incurable conditions? You can read more about this development here: https://www.technologynetworks.com/cancer/news/ai-designed-drug-targets-an-undruggable-cancer-protein-376510 View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/linkedin/groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request. MIT, Nvidia, Google & IBM-Trained. Cross Domain-Expert: Quantum, AI, Ethics, Sovereignty, Intelligence, Philanthropy. Solepoint Planning. VUI AI Cloud Architect. AI Certifications Development. Quant/AI Instructor. Castor Venture Club Member. Associate Broker. George Arnold Alexander III Director, ALEX Companies; Associate Broker, Alexander Tiffany Southwest, LLC. +1 713.918.9951 · [email protected]